Interesting article that explains how seed based c
Post# of 151984

https://news.weill.cornell.edu/news/2025/04/o...ast-cancer
Blocking CCR5 receptors down regulates the mTORc pathway and P13K (two of the major culprits, described in this article). Using Leronlimab enables the immune system to fight mTNBC with more efficiency than any one treatment on the market, to date.

